Table 1.
Patient characteristics
| N = 38 (eligible and treated on step 1) | %* | |
|---|---|---|
| Gender | ||
| Male | 25 | 66 |
| Female | 13 | 34 |
| Race | ||
| White | 30 | 79 |
| Black | 3 | 8 |
| Asian | 1 | 3 |
| Hispanic | 1 | 3 |
| Missing/unknown/pre-NCI | 3 | 8 |
| ECOG performance status | ||
| 0 | 17 | 45 |
| 1 | 18 | 47 |
| 2 | 3 | 8 |
| Primary site of cancer | ||
| GE junction | 21 | 55 |
| Cardia | 4 | 11 |
| Pyloris or antrum | 4 | 11 |
| Body, greater curvature | 2 | 5 |
| Fundus | 2 | 5 |
| Diffuse | 2 | 5 |
| Multicentric | 1 | 3 |
| Body, lesser curvature | 1 | 3 |
| Unknown | 1 | 3 |
| Histologic type | ||
| Adenocarcinoma | 36 | 95 |
| Squamous cell | 2 | 5 |
| Estimated weight loss in previous 6 months | ||
| <5% of body weight | 12 | 32 |
| 5%–10% of body weight | 9 | 24 |
| 10%–20% of body weight | 11 | 29 |
| Unknown | 6 | 16 |
| TNM staging for stomach cancer | ||
| T2N1M0 | 2 | 5 |
| T2N2M0 | 2 | 5 |
| T3NXM0 | 2 | 5 |
| T3N1MX | 1 | 3 |
| T3N1M0 | 13 | 34 |
| T3N2M0 | 3 | 8 |
| T3N0M0 | 12 | 32 |
| T4N1M0 | 2 | 5 |
| T4N0M0 | 1 | 3 |
*
Percentages may not add to 100 because of rounding error.